Even in her dual role as researcher and entrepreneur, Lucia Mori’s thirst for knowledge about how the immune system works remains as strong as ever. (Photo: University of Basel, Oliver Hochstrasser)
Even in her dual role as researcher and entrepreneur, Lucia Mori's thirst for knowledge about how the immune system works remains as strong as ever. (Photo: University of Basel, Oliver Hochstrasser) - Researchers from the University of Basel have identified cells in the immune system that are able to attack a wide range of cancer cells. Through a start-up, they are now aiming to use their discovery to develop clinically applicable treatments that will mark the next milestone in cell-based cancer therapy. In recent years, some of the greatest advances in cancer medicine have been made in personalized immune therapies. The complex process involved takes valuable time: medical professionals have to take blood from the patient, isolate the immune cells, equip these cells specifically for the fight against the type of cancer concerned, expand them, process them and then administer them to the patient. The whole procedure may take more than two weeks. "Wouldn't it be great if we could just reach into the freezer following a cancer diagnosis, and have a ready-made pack of immune cells ready to go? Regardless of the type of cancer?- asks Dr. Lucia Mori of the Department of Biomedicine at the University of Basel and the University Hospital Basel.
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
